Body and Mind - CEO, Michael Mills
CEO, Michael Mills
Source: Youtube (Capital 10X)
  • Cannabis company, Body and Mind (CSE:BAMM), has appointed its Interim CEO, Michael Mills, as its permanent Chief Executive Officer
  • Under Michael’s Interim leadership, the company opened three new revenue-generating facilities in three states in the last three months
  • He also oversaw Body and Mind’s operations throughout the unexpected challenges posed by COVID-19
  • Body and Mind is down 6.18 per cent, and is currently trading for $0.46 per share

Cannabis company, Body and Mind (CSE:BAMM), has appointed its Interim CEO, Michael Mills, as its permanent Chief Executive Officer.

During Michael’s time as an Interim CEO, the company took advantage of a number of opportunities for growth.

Since 2020 started, Body and Mind opened three new revenue-generating facilities in three different US states. These include a production facility in Nevada, a dispensary in San Diego, and a cultivation and dispensary facility in Arkansas.

Michael also oversaw the company’s operations throughout the unexpected challenges posed by the COVID-19 pandemic. A Director of Body and Mind, David Wenger, praised Michael for his work as Interim CEO.

“Michael and the team he leads at Body and Mind have diligently executed on the strategy of debt-free, strategic expansion of the company. 

“Opening three new revenue-producing facilities in the past three months in three states during challenging conditions is a testament to the company’s dedicated personnel and tenacity to move forward with our growth plan, add revenue, and expand the Body and Mind brand presence, production capacity, and dispensary footprint,” he said.

Michael expressed his appreciation for the support he received in moving to the permanent CEO role.

“I look forward to working with our team, expanding our cultivation, production, and dispensary operations across four states. 

“Our new revenue streams and balance sheet with no serviceable debt is a result of our focus on efficiency and measured growth as we continue to build scale,” he said. 

Body and Mind is down 6.18 per cent, and is currently trading for $0.46 per share, as of 3:07pm EST.

More From The Market Online

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends

Avicanna completes topical gel study

Avicanna (TSX:AVCN) has completed its observational real-world evidence study of its RHO Phyto branded cannabigerol gel.